Skip to content

REmotely Monitored, Mobile Health-Supported High Intensity Interval Training After COVID-19 Critical Illness (REMM-HIIT-COVID-19)

REmotely Monitored, Mobile Health-Supported High Intensity Interval Training After COVID-19 Critical Illness (REMM-HIIT-COVID-19)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04664101
Acronym
REMMHIIT-COVID
Enrollment
13
Registered
2020-12-11
Start date
2022-03-02
Completion date
2023-12-01
Last updated
2024-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, Critical Illness, Fitness Trackers, High Intensity Interval Training, ICU, Intensive Care Units

Keywords

critical care, Covid19, ICU, high intensity interval training, intensive care unit, critical illness, fitness trackers

Brief summary

REmotely Monitored, Mobile Health-Supported High Intensity Interval Training after COVID-19 critical illness (REMM-HIIT-COVID-19)

Detailed description

REmotely Monitored, Mhealth (REMM) supported High Intensity Interval Training (HIIT to improve recovery after Intensive Care Unit (ICU) discharge in patients with COVID-19 (REMM-HIIT-ICU-COVID) will evaluate the feasibility of clinical-, physiological- and patient-centered outcomes associated with a remotely monitored, Mhealth-supported high intensity interval rehabilitation exercise training to improve the functional recovery of survivors who have experienced critical illness with COVID-19 and have been discharged home from the hospital.

Interventions

BEHAVIORALREmotely Monitored, Mhealth (REMM) supported High Intensity Interval Training (HIIT)

REmotely Monitored, Mhealth (REMM) supported High Intensity Interval Training (HIIT) The intervention consists of high intensity interval training, consisting of a 30-minute exercise session that includes 10 x 1-minute intervals of high intensity 3x/week (e.g., Monday, Wednesday, Friday) and supplemented with 2 sessions per week of strength, balance, and mobility exercises (e.g., Tuesday, Thursday). Exercise will be supported by an activity tracker, which will allow study personnel to track patient heart rates during exercise on a daily basis, allowing them to provide individualized feedback and coaching.

OTHERComparator

Patients randomized to the control arm will receive the same technology platform and education on exercise options, including HIIT, but will return home to exercise as they see fit without personalized instruction and coaching. They will be remotely monitored, but will not receive feedback unless any adverse events are noted

Sponsors

Vanderbilt University
CollaboratorOTHER
Duke University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age \>= 18 years 2. ICU admission and subsequent discharge for primary diagnosis of COVID-19 respiratory failure or infection requiring intubation and mechanical ventilation for \> 48 hours with an ICU length of stay of ≥ 4 days. 3. Ability to ambulate with or without a gait aid prior to hospital discharge 4. Expected hospital discharge directly back to patient's residence (not to a skilled nursing facility, inpatient rehabilitation center, or long-term acute care hospital)

Exclusion criteria

1. Not ambulating independently prior to COVID-19 illness (use of a gait aid permitted) 2. Functional impairment resulting in inability to exercise at hospital discharge (including need for home oxygen requirement) 3. Unable or unwilling to follow coaching via mobile-health iPhone interaction 4. Any absolute contraindications to exercise (as outlined in the American Thoracic Society Guidelines for Cardiopulmonary Exercise Testing), including but not limited to: 1. Recent (\< 5 days) acute primary cardiac event 2. Unstable Angina 3. Uncontrolled dysrhythmias causing symptoms or hemodynamic compromise 4. Symptomatic aortic stenosis 5. Uncontrolled symptomatic heart failure 6. Acute myocarditis or pericarditis 7. Suspected or known dissecting aneurysm

Design outcomes

Primary

MeasureTime frame
Peak oxygen consumption (V02P) at 3 months after hospital discharge3 months post-discharge

Secondary

MeasureTime frameDescription
Change in 6 minute walk test distance from baseline to 3 months after hospital dischargeHospital discharge (baseline), 3 months post-dischargedistance walked in 6 minutes
Change in muscle mass from baseline to 3 months after hospital dischargeHospital discharge (baseline), 3 months post-dischargeMeasured by muscle sound
Change in muscle strength from baseline to 3 months after hospital dischargeHospital discharge (baseline), 3 months post-dischargeMeasured by Fried Frailty (includes Hand Grip strength)
Cognition at 3 months after hospital discharge3 months post-dischargeMeasured by Repeatable Battery for Assessment of Neuropsychological Status (RBANS)
Change in cognition from 3 months to 6 months after hospital discharge.3 months post-discharge, 6 months post-hospital dischargeMeasured by PROMIS Cognitive function
Change in quality of life from baseline to 3 months after hospital discharge.Hospital discharge (baseline), 3 months post-dischargeMeasured by Sociodemographic survey
Change in quality of life from baseline to 3 months to 6 months after hospital discharge.3 months post-discharge, 6 months post-hospital dischargeMeasured by Sociodemographic Survey
Change in cognition from baseline to 3 months after hospital discharge.Hospital discharge (baseline), 3 months post-dischargeMeasured by Montreal Cognitive Assessment (MOCA)

Other

MeasureTime frameDescription
Change in biomarkers of aging and resilience, and mitochondrial function from baseline to 3 months post-dischargeHospital discharge (baseline), 3 months post-dischargeMeasured by peripheral blood mononuclear cell (PBMC)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026